The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2014

Filed:

Oct. 03, 2012
Applicants:

Charlotte Emig, Gibsonia, PA (US);

Vivienne S Marshall, San Antonio, TX (US);

Richard a Banas, Turtle Creek, PA (US);

Inventors:

Charlotte Emig, Gibsonia, PA (US);

Vivienne S Marshall, San Antonio, TX (US);

Richard A Banas, Turtle Creek, PA (US);

Assignee:

Stemnion, Inc., Pittsburgh, PA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 35/50 (2006.01); A61Q 19/00 (2006.01); A61K 8/98 (2006.01); C12N 5/073 (2010.01); C12N 5/071 (2010.01); A61K 35/12 (2006.01);
U.S. Cl.
CPC ...
A61K 35/50 (2013.01); A61K 35/12 (2013.01); A61Q 19/00 (2013.01); A61K 8/982 (2013.01); C12N 2501/11 (2013.01); A12N 2502/02 (2013.01); C12N 5/0605 (2013.01); C12N 5/0629 (2013.01);
Abstract

The invention is directed to substantially purified amnion-derived cell populations, compositions comprising the substantially purified amnion-derived cell populations, and to methods of creating such substantially purified amnion-derived cell populations, as well as methods of use. The invention is further directed to antibodies, in particular, monoclonal antibodies, that bind to amnion-derived cells or, alternatively, to one or more amnion-derived cell surface protein markers. The invention is further directed to methods for producing the antibodies, methods for using the antibodies, and kits comprising the antibodies.


Find Patent Forward Citations

Loading…